Skip to content

Clinical trials

Respiratory Tract Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Country / region: South Korea Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20121
20131
20144
20151
20161
20174
20181
20194
20203
20212
20224
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting5
Recruiting4
Terminated4
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Eli Lilly and Company3
Revolution Medicines, Inc.3
Blueprint Medicines Corporation2
Hoffmann-La Roche2
Merck Sharp & Dohme LLC2
Pfizer2
United Therapeutics2
Upstream Bio Inc.2
AVEO Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases35
Lung Diseases28
Lung Neoplasms14
Carcinoma, Non-Small-Cell Lung13
Neoplasms13
Neoplasms by Site12
Respiratory Tract Neoplasms12
Thoracic Neoplasms11
Asthma10
Bronchial Diseases10

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.